Tilray Brands, Inc. (TLRY)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $2.35
- As of
Kresmion compiles this page from TLRY's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Tilray Brands, Inc. (TLRY): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-10-08.
See the full TLRY dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for TLRY on one page. Preview it with sample data, then open it live with a free account.
Preview the TLRY dossierActive events for TLRY
- lowEarnings below estimates
Q4-2026: EPS $-0.43 vs $-0.0136 estimate, -0.42 on a near-zero consensus
- lowEarnings below estimates
Q2-2026: EPS $-0.43 vs $-0.0136 estimate, -0.42 on a near-zero consensus
- mediumEarnings below estimates
Q1-2027: Missed consensus by 55.8%, EPS $-0.32 vs $-0.2054 estimate
- mediumEarnings below estimates
Q3-2026: Missed consensus by 55.8%, EPS $-0.32 vs $-0.2054 estimate
- mediumEarnings below estimates
Q1-2027: Missed consensus by 64.3%, EPS $-0.32 vs $-0.1948 estimate
FREE, NO ACCOUNT
Every event on TLRY, as it fires
You are seeing 5 of 14 events recorded on TLRY since 2026-05-29.
The five above landed across 3 days. The other 9 were recorded on 4 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, TLRY
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on TLRY
TLRY against its peers
TLRY's operating margin of -6.9% ranks in the 58th percentile of 17 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-05-31.
| Metric | TLRY | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 915M USD | 181M USD | 97 | 16 |
| Gross margin | 28.4% | 50.3% | 14 | 17 |
| Operating margin | -6.9% | -11.0% | 58 | 17 |
| Net margin | -13.3% | -20.6% | 69 | 17 |
| Return on equity | -7.5% | -25.1% | 72 | 15 |
| 1 year | -75.6% | -31.7% | 13 | 19 |
Peers (19): VREOF, VRNO, NIKA, ELTP, EOLS, KMDA, AQST, TKNO, CGC, CRLBF, ADCT, AKBA, CRDL, DERM, HROW, GLAS, TSNDF, BGM, CRON. Left out: BORAY (no annual filing), LFCR (no annual filing), EVO (period gap), ASRT.D (no annual filing), PHBI (period gap), OGI (period gap). Fiscal periods ending between 2025-09-30 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (TLRY: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in TLRY on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on TLRY in the last 180 days.
Upstream: SEC EDGAR filings for TLRY
Kresmion, "Tilray Brands, Inc. (TLRY) institutional holdings and SEC filings", data as of 2026-10-26, https://kresmion.com/research/TLRY. Upstream data: SEC EDGAR filings for TLRY.
Link to this data (HTML):
<a href="https://kresmion.com/research/TLRY">Tilray Brands, Inc. (TLRY) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow TLRY on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to TLRY for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.